Why UBS and Goldman Sachs are boosting their gold forecasts
UBS strategist Joni Teves is breaking her own rules — so are strategists at Goldman Sachs.
UBS upgrades Max Healthcare to 'buy'; stock gains up to 3%
The company within the next 3 years has plans to double its bed capacity, a move that is expected to bode well for the ...
Slower growth, earnings and tariff risks are taking shine off India's stock market: UBS
Kelvin Tay from UBS Global Wealth Management talks about India's market outlook and says in the current inflationary ...
UBS’s stock got clobbered after earnings. Deutsche Bank says it’s now a buy.
UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...
UBS whistleblower verdict thrown out despite US Supreme Court win
A former UBS bond strategist who persuaded the U.S. Supreme Court to make it easier for corporate whistleblowers to win ...
UBS Reaffirms Their Hold Rating on Nestlé SA (NSRGF)
UBS analyst Guillaume Delmas maintained a Hold rating on Nestlé SA (NSRGF – Research Report) today and set a price target of CHF80.00. The ...
Despite tariff fears European stocks have outperformed Wall Street this year. Here’s why UBS thinks that will continue.
It’s Valentine’s Day, and love is most definitely in the air for European stocks. Consider these numbers. The STOXX Europe ...
UBS CEO expects more clarity on capital rules in May
UBS should have more clarity on the amount of capital it will need to hold under new Swiss banking regulations currently ...
UBS optimistic about Swiss economy, sees risks from Eurozone and US tariffs
However, UBS has identified two principal risks that could potentially undermine Swiss economic growth. One concern is the possibility that the Eurozone may not experience the forecasted recovery in ...
UBS Wealth Calls Out Payment Triggers for Catastrophe Bonds
The models that determine when catastrophe bonds pay out are falling short, as the financial compensation triggered by ...
UBS sees high chance of CDU/CSU win in German election
The Political Probability Monitor indicates a 94% probability of the CDU/CSU winning the most seats and a 93% chance that CDU leader Friedrich Merz could be appointed the next chancellor.
Max Healthcare shares gain 3% as UBS upgrades to 'buy', sees 18% upside
Analysts suggest that Max Healthcares' plan to double its bed capacity within the next three years is expected to further enhance its growth prospects.